Advertisement
Advertisement
PRLD
Prelude Therapeutics Incorporated
4.31
USDSponsored
-0.54
-11.13%
Sep 23, 16:00 UTC -4
Closed
After-Market
4.30
0.00
-0.12%
Prelude Therapeutics Incorporated Financial Snapshot
| Market Cap | 343.55M |
| Beta | 0.97 |
| Earnings Per Share (EPS) | -0.73 |
| Price-to-Book (P/B) Ratio | 2.80 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -75.35% |
| Current Ratio | 4.07% |
| Free Cash Flow | -37.26M |
